Literature DB >> 10222452

Continuing education in neurometabolic disorders--serine deficiency disorders.

T J de Koning1, B T Poll-The, J Jaeken.   

Abstract

Serine deficiency disorders comprise a new group of inborn errors of serine metabolism. Patients affected with these disorders present with major neurological symptoms including congenital microcephaly, seizures, psychomotor retardation or polyneuropathy. The diagnosis of serine deficiency is based on the detection of low concentrations of the amino acids serine and glycine in fasted plasma and cerebrospinal fluid (CSF). Amino acid analysis of cerebrospinal fluid is preferable over plasma analysis, because the deficiencies are more pronounced in CSF. Because of the interference of amino acids absorbed from the diet, diagnostic procedures have to be performed in the fasted state. Although the disorders are probably rare and not many cases have been reported, recognition of serine deficiency is important, given the fact that the disorders are potentially treatable. The clinical symptoms respond well to amino acid replacement therapy. So far, three serine deficiency disorders have been reported; 3-phosphoglycerate dehydrogenase deficiency, 3-phosphoserine phosphatase deficiency and a still unexplained serine deficiency disorder. In this paper, we will discuss the various serine deficiency disorders, their biochemical abnormalities and the results of amino acid replacement therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10222452     DOI: 10.1055/s-2007-973447

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  8 in total

1.  The magnetic resonance revolution in brain imaging: impact on neonatal intensive care.

Authors:  N J Robertson; J S Wyatt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-05       Impact factor: 5.747

2.  Effects of essential amino acid deficiency: down-regulation of KCC2 and the GABAA receptor; disinhibition in the anterior piriform cortex.

Authors:  James W Sharp; Catherine M Ross-Inta; Irène Baccelli; John A Payne; John B Rudell; Dorothy W Gietzen
Journal:  J Neurochem       Date:  2013-09-12       Impact factor: 5.372

3.  Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency--a neurometabolic disorder associated with reduced L-serine biosynthesis.

Authors:  L W Klomp; T J de Koning; H E Malingré; E A van Beurden; M Brink; F L Opdam; M Duran; J Jaeken; M Pineda; L Van Maldergem; B T Poll-The; I E van den Berg; R Berger
Journal:  Am J Hum Genet       Date:  2000-10-27       Impact factor: 11.025

4.  3-Phosphoglycerate dehydrogenase, a key enzyme for l-serine biosynthesis, is preferentially expressed in the radial glia/astrocyte lineage and olfactory ensheathing glia in the mouse brain.

Authors:  M Yamasaki; K Yamada; S Furuya; J Mitoma; Y Hirabayashi; M Watanabe
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 5.  The intrinsic disorder alphabet. III. Dual personality of serine.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2015-03-17

Review 6.  Cerebral folate deficiency.

Authors:  Keith Hyland; John Shoffner; Simon J Heales
Journal:  J Inherit Metab Dis       Date:  2010-07-29       Impact factor: 4.982

Review 7.  Peripheral neuropathy and inborn errors of metabolism in adults.

Authors:  F Sedel; C Barnerias; O Dubourg; I Desguerres; O Lyon-Caen; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

8.  Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids.

Authors:  T J De Koning; M Duran; L Van Maldergem; M Pineda; L Dorland; R Gooskens; J Jaeken; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.